Hyperkalemia is an important complication of adrenalectomy for patients with primary aldosteronism (PA). The frequency of hyperkalemia after medication using mineralocorticoid receptor antagonists ...

The incidence of hyperkalemia in patients with normal renal function who are treated with dual RAAS inhibitors in the absence of other potassium-retaining therapies seems to be approximately 5%.

These investigators looked at the clinical impact of hyperkalemia and the use of renin-angiotensin-aldosterone system inhibitors on a large cohort of patients with heart failure. Women, Acne ...

Hyperkalemia is a high level of potassium in the body. When potassium in the blood is above 5.5 mmol/l, it is called hyperkalemia and can lead to fatal changes in heart rhythm.

IntroductionHyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease (CKD), diabetes mellitus, or heart failure.1–3 Hyperkalemia represents one of the ...

Hyperkalemia Pipeline Promising — Novel agents look good in trials, although long-term safety and efficacy remain to be seen. by Kristina Fiore, Staff Writer, MedPage Today November 30, 2014 ...

Individuals with kidney issues should exercise caution with coconut and banana consumption due to their high potassium ...

Total number of investigator-reported hyperkalemia events was 225 (77.7 per 100 person-years) in the patiromer group and 316 (118.2 per 100 person-years) in the placebo group ...

Hyperkalemia can cause symptoms such as muscle weakness, numbness, chest pain, heart palpitations and nausea. Even though most patients with high potassium levels experience no symptoms, ...

Hyperkalemia - market overview Hyperkalemia refers to the increased levels of potassium in the blood serum. The word hyperkalemia is derived from three words hyper, Kalium, and emia.

Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Hyperkalemia - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.This ...